 | • レポートコード：QFJ1-4422 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・レノックス・ガストー症候群治療の市場動向 ・企業の競争状況、市場シェア ・レノックス・ガストー症候群治療の種類別市場規模と予測2016-2027（非外科的治療、外科的治療） ・レノックス・ガストー症候群治療の用途別市場規模と予測2016-2027（発作、眼球異常、脳波所見、その他） ・レノックス・ガストー症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・レノックス・ガストー症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・レノックス・ガストー症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・レノックス・ガストー症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・レノックス・ガストー症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eisai Co., Ltd.、GlaxoSmithKline plc.、H. Lundbeck A/S、Johnson & Johnson Services, Inc.、Supernus Pharmaceuticals, Inc） ・結論 |
Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
Market Analysis and Insights: Global Lennox-Gastaut Syndrome Treatment Market
The global Lennox-Gastaut Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lennox-Gastaut Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lennox-Gastaut Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lennox-Gastaut Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lennox-Gastaut Syndrome Treatment market.
Global Lennox-Gastaut Syndrome Treatment Scope and Market Size
Lennox-Gastaut Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lennox-Gastaut Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-surgical Treatment
Surgical Treatment
Segment by Application
Seizures
Ocular Abnormality
EEG Findings
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-surgical Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Lennox-Gastaut Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Seizures
1.3.3 Ocular Abnormality
1.3.4 EEG Findings
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lennox-Gastaut Syndrome Treatment Market Perspective (2016-2027)
2.2 Lennox-Gastaut Syndrome Treatment Growth Trends by Regions
2.2.1 Lennox-Gastaut Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lennox-Gastaut Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Lennox-Gastaut Syndrome Treatment Industry Dynamic
2.3.1 Lennox-Gastaut Syndrome Treatment Market Trends
2.3.2 Lennox-Gastaut Syndrome Treatment Market Drivers
2.3.3 Lennox-Gastaut Syndrome Treatment Market Challenges
2.3.4 Lennox-Gastaut Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lennox-Gastaut Syndrome Treatment Players by Revenue
3.1.1 Global Top Lennox-Gastaut Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Lennox-Gastaut Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lennox-Gastaut Syndrome Treatment Revenue
3.4 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio
3.4.1 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lennox-Gastaut Syndrome Treatment Revenue in 2020
3.5 Lennox-Gastaut Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Lennox-Gastaut Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Lennox-Gastaut Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lennox-Gastaut Syndrome Treatment Breakdown Data by Type
4.1 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Type (2022-2027)
5 Lennox-Gastaut Syndrome Treatment Breakdown Data by Application
5.1 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lennox-Gastaut Syndrome Treatment Market Size (2016-2027)
6.2 North America Lennox-Gastaut Syndrome Treatment Market Size by Type
6.2.1 North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Application
6.3.1 North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Lennox-Gastaut Syndrome Treatment Market Size by Country
6.4.1 North America Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Lennox-Gastaut Syndrome Treatment Market Size (2016-2027)
7.2 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type
7.2.1 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application
7.3.1 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Lennox-Gastaut Syndrome Treatment Market Size by Country
7.4.1 Europe Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lennox-Gastaut Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Type
9.2.1 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Application
9.3.1 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country
9.4.1 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eisai Co., Ltd.
11.1.1 Eisai Co., Ltd. Company Details
11.1.2 Eisai Co., Ltd. Business Overview
11.1.3 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Introduction
11.1.4 Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
11.1.5 Eisai Co., Ltd. Recent Development
11.2 GlaxoSmithKline plc.
11.2.1 GlaxoSmithKline plc. Company Details
11.2.2 GlaxoSmithKline plc. Business Overview
11.2.3 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Introduction
11.2.4 GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline plc. Recent Development
11.3 H. Lundbeck A/S
11.3.1 H. Lundbeck A/S Company Details
11.3.2 H. Lundbeck A/S Business Overview
11.3.3 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Introduction
11.3.4 H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
11.3.5 H. Lundbeck A/S Recent Development
11.4 Johnson & Johnson Services, Inc.
11.4.1 Johnson & Johnson Services, Inc. Company Details
11.4.2 Johnson & Johnson Services, Inc. Business Overview
11.4.3 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Introduction
11.4.4 Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Services, Inc. Recent Development
11.5 Supernus Pharmaceuticals, Inc
11.5.1 Supernus Pharmaceuticals, Inc Company Details
11.5.2 Supernus Pharmaceuticals, Inc Business Overview
11.5.3 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Introduction
11.5.4 Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
11.5.5 Supernus Pharmaceuticals, Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-surgical Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Lennox-Gastaut Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Lennox-Gastaut Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lennox-Gastaut Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions (2016-2021)
Table 8. Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions (2022-2027)
Table 10. Lennox-Gastaut Syndrome Treatment Market Trends
Table 11. Lennox-Gastaut Syndrome Treatment Market Drivers
Table 12. Lennox-Gastaut Syndrome Treatment Market Challenges
Table 13. Lennox-Gastaut Syndrome Treatment Market Restraints
Table 14. Global Lennox-Gastaut Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Lennox-Gastaut Syndrome Treatment Market Share by Players (2016-2021)
Table 16. Global Top Lennox-Gastaut Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Treatment as of 2020)
Table 17. Ranking of Global Top Lennox-Gastaut Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Lennox-Gastaut Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lennox-Gastaut Syndrome Treatment Product Solution and Service
Table 21. Date of Enter into Lennox-Gastaut Syndrome Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Lennox-Gastaut Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eisai Co., Ltd. Company Details
Table 62. Eisai Co., Ltd. Business Overview
Table 63. Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Product
Table 64. Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 65. Eisai Co., Ltd. Recent Development
Table 66. GlaxoSmithKline plc. Company Details
Table 67. GlaxoSmithKline plc. Business Overview
Table 68. GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Product
Table 69. GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline plc. Recent Development
Table 71. H. Lundbeck A/S Company Details
Table 72. H. Lundbeck A/S Business Overview
Table 73. H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Product
Table 74. H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 75. H. Lundbeck A/S Recent Development
Table 76. Johnson & Johnson Services, Inc. Company Details
Table 77. Johnson & Johnson Services, Inc. Business Overview
Table 78. Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Product
Table 79. Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Services, Inc. Recent Development
Table 81. Supernus Pharmaceuticals, Inc Company Details
Table 82. Supernus Pharmaceuticals, Inc Business Overview
Table 83. Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Product
Table 84. Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 85. Supernus Pharmaceuticals, Inc Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lennox-Gastaut Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Non-surgical Treatment Features
Figure 3. Surgical Treatment Features
Figure 4. Global Lennox-Gastaut Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 5. Seizures Case Studies
Figure 6. Ocular Abnormality Case Studies
Figure 7. EEG Findings Case Studies
Figure 8. Others Case Studies
Figure 9. Lennox-Gastaut Syndrome Treatment Report Years Considered
Figure 10. Global Lennox-Gastaut Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Lennox-Gastaut Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions (2022-2027)
Figure 14. Global Lennox-Gastaut Syndrome Treatment Market Share by Players in 2020
Figure 15. Global Top Lennox-Gastaut Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Lennox-Gastaut Syndrome Treatment Revenue in 2020
Figure 17. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Lennox-Gastaut Syndrome Treatment Market Share by Type (2016-2027)
Figure 21. North America Lennox-Gastaut Syndrome Treatment Market Share by Application (2016-2027)
Figure 22. North America Lennox-Gastaut Syndrome Treatment Market Share by Country (2016-2027)
Figure 23. United States Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lennox-Gastaut Syndrome Treatment Market Share by Type (2016-2027)
Figure 27. Europe Lennox-Gastaut Syndrome Treatment Market Share by Application (2016-2027)
Figure 28. Europe Lennox-Gastaut Syndrome Treatment Market Share by Country (2016-2027)
Figure 29. Germany Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Share by Region (2016-2027)
Figure 39. China Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lennox-Gastaut Syndrome Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Lennox-Gastaut Syndrome Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Lennox-Gastaut Syndrome Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eisai Co., Ltd. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline plc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
Figure 60. H. Lundbeck A/S Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
Figure 61. Johnson & Johnson Services, Inc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
Figure 62. Supernus Pharmaceuticals, Inc Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
レノックスガストー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…- レノックスガストー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…
- レノックスガストー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…
- 世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…
- 世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…